Scientific Opinion on the substantiation of health claims related to alpha-lipoic acid and “protection of the nerve system” (ID 3157) and increase in insulin sensitivity (ID 3158) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

alpha-lipoic acid, nervous system, insulin sensitivity, health claims
First published in the EFSA Journal
30 June 2011
8 April 2011
Scientific Opinion

No abstract available

Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
nda [at]
EFSA Journal 2011;9(6):2202 [14 pp.].
Question Number
On request from
European Commission